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ABSTRACT
We have screened peptoid microarrays to identify
specific ligands for the RNA hairpin precursor of
miR-21, a microRNA involved in cancer and heart
disease. Microarrays were printed by spotting a
library of 7680 N-substituted oligoglycines (pep-
toids) onto glass slides. Two compounds on the
array specifically bind RNA having the sequence
and predicted secondary structure of the miR-21
precursor hairpin and have specific affinity for
the target in solution. Their binding induces a con-
formational change around the hairpin loop, and
the most specific compound recognizes the loop
sequence and a bulged uridine in the proximal
duplex. Functional groups contributing affinity and
specificity were identified, and by varying a critical
methylpyridine group, a compound with a dissocia-
tion constant of 1.9mM for the miR-21 precursor
hairpin and a 20-fold discrimination against a
closely-related hairpin was created. This work
describes a systematic approach to discovery of
ligands for specific pre-defined novel RNA struc-
tures. It demonstrates discovery of new ligands for
an RNA for which no specific lead compounds were
previously known by screening a microarray of small
molecules.
INTRODUCTION
The discovery of microRNAs (miRNAs) and their essen-
tial role in translational regulation has brought to light
a promising new class of RNA therapeutic targets.
MiRNAs are short, naturally occurring RNA molecules
that regulate translation of messenger RNAs by binding
to sequences in their 30-untranslated regions (1). They are
important regulators of development and cellular
responses to stress (2,3). Consistent with their ubiquitous
role in regulating translation, aberrant expression of
speciﬁc miRNAs is often associated with disease of dis-
regulated translation.
Cancer and cardiovascular diseases are among the dis-
ease for which this association is well established.
Signature proﬁles of miRNA expression accompany the
cancerous state, and a miRNA that is dramatically up-
regulated in the expression signatures of many solid
tumors is miR-21 (4). This miRNA targets tumor suppres-
sor genes, including pro-apoptotic genes such as PDCD4
(programmed cell death 4) (5,6). By suppressing transla-
tion of pro-apoptotic genes, miR-21 contributes to an
essential feature of the cancer phenotype, a diminished
ability to undergo programmed cell death. Inhibition of
miR-21 function renders cancer cells vulnerable to self-
destruction (7). Increased expression of miR-21 is also a
characteristic of the miRNA proﬁle associated with patho-
logical remodeling of heart tissue in response to persistent
stress (8–10). This eﬀect is characterized by increased car-
diac size and re-expression of fetal genes, and miR-21
appears to regulate these responses. Thus, increased
expression of miR-21 is associated with cancer and heart
disease, implicating it as a potential therapeutic target in
both of these conditions (11,12).
Like other miRNAs, miR-21 is produced by excision
from a longer primary transcript, where it is found in
the stem of a hairpin structure (1). Endonucleases cleave
the hairpin from the primary transcript and remove the
apical loop. Cleavage from the primary transcript by the
ribonuclease Drosha is emerging as an important point
at which miRNA expression is regulated. Expression of
miR-21 is promoted by factors that recruit the micropro-
cessor, the complex of Drosha and associated proteins, to
its primary transcript (13). Conversely, the RNA-binding
protein Lin-28 mediates diminished processing of Let-7
family pri-miRNAs by association with the loop of the
precursor hairpin (14–16). This natural regulation of
miRNA processing suggests a strategy for manipulating
miRNA levels: binding of a small molecule within or adja-
cent to the hairpin loop of a miRNA precursor could
interfere with its maturation.
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speciﬁc, pre-deﬁned RNAs remains a signiﬁcant challenge.
As a result, speciﬁc ligands are known for only a small
number of disease-related RNAs (17). Structure-based
methods have been possible in a few cases (18–21), but
the lack of high-resolution structural data for most
RNAs of interest favors screening of diverse chemical
collections and combinatorial libraries for speciﬁc RNA-
binding molecules (22–25). In the study presented here, we
have screened a combinatorial library of N-substituted
oligoglycines, commonly called peptoids (26), for mole-
cules with speciﬁc aﬃnity for the hairpin loop of the
miR-21 precursor. Peptoids are peptidomimetic com-
pounds that are cell permeable (27), protease resistant,
and easily synthesized in highly diverse libraries by solid
phase ‘split-pool’ synthesis (28–31).
We screened the peptoid library in a microarray format.
Microarrays of surface-bound small molecules are increas-
ingly important tools for high-throughput screening and
discovery of new ligands (32). They have been used to
discover new protein–small molecule interactions (33–35)
and to proﬁle the speciﬁcities of known RNA-binding
antibiotics (36–38). The microarray format oﬀers potential
beneﬁts as a means to discover new ligands. Thousands of
compounds can be screened simultaneously on microar-
rays with low requirements for costly RNA samples, and
many replicate arrays can be printed from a single chem-
ical library, allowing the same library to be screened
against multiple targets or in multiple screening trials
with the same target. We have used peptoid microarrays
as the foundation for a system of RNA ligand discovery in
which lead compounds with speciﬁc aﬃnity are identiﬁed
by screening, and the positive, speciﬁc molecular interac-
tions discovered are utilized to create improved ligands.
MATERIALS AND METHODS
Abbreviations
DMF: dimethylformamide; NMM: N-methyl morpholine;
DIC: diisopropylcarbodiimide; HBTU: O-(benzotriazol-
1-yl)-N,N,N0,N0-tetramethyluronium hexaﬂuorophosphate;
HOBT: 1-hydroxybenzotriazole; NMP: N-methylpyrroli-
dinone; DMSO: dimethylsulfoxide; EDTA: ethylenedia-
minetetraacetic acid; PBS: phosphate buﬀered saline
(137mM NaCl, 2.7mM KCl, 10mM Na2HPO4,2 m M
KH2PO4, pH 7.4)
General procedures
Library synthesis and all peptoid syntheses were carried
out in fritted glass peptide synthesis reaction vessels
(Chemglass). Matrix assisted laser desorption ionization
(MALDI) mass spectrometry (Voyager DE Pro, ABI)
was done using a-cyano-4-hydroxycinnamic acid as
matrix. Analytical and preparative HPLC were carried
out on C18 columns (Vydac), eluting with a gradient
from 100% H2O to 20% acetonitrile (with constant
0.1% triﬂuoroacetic acid). Except where noted, all
reagents were obtained from Sigma.
Synthesis of peptoid library
Polystyrene macrobeads (2.0g; 500–560mm; substitution:
0.56mmol/g, Rapp Polymere) were swollen in dimethyl-
formamide (DMF) at room temperature overnight. The
beads were treated twice with 20% (v/v) piperidine
in DMF at room temperature with shaking (230 r.p.m.)
for 15min (2 20ml). The reaction vessel was drained and
the beads were thoroughly washed with DMF (6 20ml).
Cysteine, glycine and arginine residues were coupled using
standard manual peptide synthesis protocols. To couple
the cysteine, 10ml 200mM Fmoc-Cys(Trt)-OH solution
was added to the beads followed by 10ml 200mM
solution of O-(benzotriazol-1-yl)-N,N,N0,N0-tetramethy-
luronium hexaﬂuorophosphate (HBTU) and 1-hydroxy-
benzotriazole (HOBT) in DMF containing 400mM
N-methyl morpholine (NMM). The reaction vessel was
shaken at room temperature for 1h. The vessel was
drained and washed with DMF (6 20ml). It was treated
twice with 20% piperidine in DMF for 15min (2 20ml),
drained and washed thoroughly with DMF. The same
protocol was repeated to couple the two glycine residues
and an arginine residue using Fmoc-Gly-OH and Fmoc-
Arg(Pbf)-OH. A small portion of the beads was set aside
after coupling arginine for spotting of control features
following deprotection and cleavage from the support.
Combinatorial peptoid synthesis was performed on
these beads following deprotection of the terminal amine
by treatment with 20% piperidine in DMF. The beads
were distributed equally into 21 peptide synthesis reaction
vessels. Monomer addition was carried out in two steps
(29). In step 1, acylation was carried out using chloroace-
tic acid and di-isopropylcarbodiimide (DIC). To each
vessel was added 1.5ml of 2M chloroacetic acid in anhy-
drous DMF and 1.5ml 2M DIC in anhydrous DMF. The
reaction vessels were shaken at 378C for 10min. The ves-
sels were drained, and the beads were washed with DMF
(6 5ml). In step 2, displacement of the chloride by the
primary amine was carried out. The beads in each of
the vessels were treated with 1 of 21 primary amines at
2M concentrations in N-methylpyrrolidinone (NMP)
at 378C with shaking. The amines used were tert-butyl
N-(4-aminobutyl)carbamate (TCI America), 1-amino-
2-methylpropane, 3-amino-1-propene, glycine-t-butyl
ester, 2-aminomethylfuran, 2-(aminomethyl)tetrahydo-
furan, O-t-butyl-2-aminoethanol (CSPS Pharmaceuticals,
San Diego, USA), 3-(2-aminoethyl)indole, R-(+)-1-phe-
nylethylamine, 2,4-dimethoxybenzylamine, 2,2-diphenyl-
ethylamine, 2-(1-cyclohexenyl)ethylamine, 4-aminomethyl-
boc-piperidine (Fluka), cyclobutylamine, 3,4-(methylene-
dioxy)benzylamine (Acros), 2-(4-imidazolyl)ethylamine,
4-(2-aminoethyl)phenol, 4-aminoethylmorpholine, 4-ami-
nomethylpyridine, 1-(3-aminopropyl)-2-pyrrolidinone
and 2-(2-aminoethylamino)-5-nitropyridine. These
amines are illustrated in their unprotected forms in
Figure 1B. The vessels were drained and washed thor-
oughly with DMF (6 5ml). A small portion of the
beads were set aside after the ﬁrst cycle of peptoid cou-
pling to spot as control features on the arrays. The beads
in each of the reaction vessels were pooled into a 250ml
peptide synthesis vessel, drained, suspended in 50ml
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The beads were then distributed equally into 21 reaction
vessels and the acylation and displacement procedures
were repeated for two more monomer residues. After com-
pletion of the library synthesis, the beads were washed
with dichloromethane (5 20ml) and ﬁnally with absolute
ethanol (5 20ml). The beads were manually sorted into
96-well polystyrene plates, one bead per well. To remove
side chain protective groups from amine, carboxyl and
hydroxyl side chains and to cleave the library elements
from the beads, 30ml of a cleavage cocktail consisting
of 47.5% TFA, 47.5% dichloroethane, 2.5% tri-
isopropylsilane and 2.5% water was added to each well.
The plates were sealed and incubated at room temperature
for 6h, after which the cleavage cocktail was allowed
to evaporate in a fume hood overnight. The peptoids
were dissolved in 50ml of acetonitrile/water (1:1) and
transferred quantitatively into a duplicate set of 384-well
polystyrene plates. Solvent was evaporated from one
set of plates and the residue in each well was dissolved
in 50ml dimethylsulfoxide (DMSO). The remaining set
of plates was reserved for mass spectral analysis of ‘hit’
compounds.
Library characterization
Seventeen individual library elements (i.e. products from
individual beads) were randomly chosen from the peptoid
library and analyzed by MALDI mass spectrometry.
The mass spectra indicated a single major component in
each of the products. Each of the selected library elements
was sequenced by MS/MS. Of the 21, 16 possible side
chains were represented at least once, with the most
common frequency of occurrence being two (nine of the
side chains). The highest frequency of occurrence in this
sample is seven times, for one side chain. This distribution
is consistent with the random incorporation of submono-
mers expected from split-pool synthesis.
Printing of microarrays
Microarrays were printed on 100  300 glass microscope
slides. Prior to spotting, the slides were cleaned and
coated with 3-glycidoxypropyltrimethoxysilane and poly-
ethylene glycol as described by Maskos and Southern (39).
One face of each polyethylene glycol functionalized slide
was treated with 20mM N-(p-maleimidophenyl) isocya-
nate (Pierce) in dry DMSO in a custom-made reaction
chamber (35). After overnight incubation at room tem-
perature, the slides were washed several times with
DMSO and acetonitrile. Cysteine-terminated peptoids
dissolved in DMSO were printed to these slides at a den-
sity of 500 spots/cm
2 with an ArrayIT robotic printer
(Telechem International, Inc.). After spotting, the slides
were left on the printer at room temperature for 16h.
To block unreacted maleimide groups, the slides were
then immersed in a 1% (v/v) solution of 2-mercaptoetha-
nol in DMF for 2h. All the slides were then washed in
DMF, acetonitrile and iso-propanol, dried and stored in
darkness under vacuum until used.
Large scale synthesis of peptoids
Synthesis was performed on 100mg Knorr Amide MBHA
resin (substitution: 0.78mmol/g; Nova Biochem). The
beads were swollen in DMF for 2h, drained, treated
twice with 20% piperidine in DMF for 15min (2 5ml)
and washed thoroughly with DMF (6 5ml). Two milli-
liters of 200mM solution of Fmoc-gly-OH in DMF was
added followed by 2ml of 200mM solution of HBTU/
HOBT in DMF containing 400mM NMM. The reaction
vessel was shaken at room temperature for 1h. The beads
were washed with DMF (6 5.0ml). The beads were trea-
ted twice with 20% piperidine in DMF for 15min
(2 5ml) drained and washed with DMF (6 5.0ml).
Another glycine residue and an arginine residue were
coupled in the same manner. Two milliliters of a 2M solu-
tion of the chloroacetic acid in anhydrous DMF was
added to the resin-bound amine at 378C followed by
2ml of 2.0M DIC in anhydrous DMF. The resin was
mixed for 10min, drained and then washed with DMF
(6 2.0ml). The chloride was displaced by addition of
2ml of a 2.0M solution of the furfuryl amine in NMP,
allowed to react for 60min at 378C. The resin was drained
and then washed with DMF (6 2.0ml). The monomer
addition steps were repeated for O-t-butyl-2-aminoethanol
and 4-(aminomethyl) pyridine. The beads were washed
with dichloromethane (5 5ml). The peptoid was released
from the resin with concomitant removal of the protecting
groups by treating the beads with 5ml of 95% TFA, 2.5%
tri-isopropylsilane and 2.5% water. The cleavage cocktail
was concentrated by blowing argon over the solution. The
concentrated ﬁltrate was dissolved in 5ml of 1:1 acetoni-
trile/water and lyophilized. The residue was puriﬁed by
HPLC.
Compound 2 was synthesized in a similar manner using
allyl amine, tetrahydofurfuryl amine and tryptamine in the
chloride displacement steps, and 3 was synthesized in a
similar manner using cyclobutylamine, tetrahydrofurfury-
lamine amine and allylamine. Methyl side chains were
incorporated into derivatives of 1 by using a 2M solution
of methylamine in THF in the chloride displacement step
of peptoid synthesis.
General RNA sample preparation
RNA samples were obtained puriﬁed from Dharmacon
with the 20-ACE protective groups left in place.
Protective groups were removed immediately prior to
use according to manufacturer’s protocol. The depro-
tected RNA was precipitated with ethanol and sodium
acetate prior to use.
Tm measurement by UV-monitored thermal denaturation
RNA melting points were measured with a Cary 100Bio
UV spectrophotometer (Varian). RNA samples were dis-
solved in phosphate buﬀer saline (137mM NaCl, 2.7mM
KCl, 10mM Na2HPO4, 2mM KH2PO4, pH 7.4) (PBS)
buﬀer and overlayed with mineral oil in 1cm path
length quartz cells. Absorbance at 260nm was measured
as the temperature varied from 14 to 958C at a rate of
2.08C/min. Melting points were determined from the ﬁrst
5488 Nucleic Acids Research, 2009, Vol. 37,No. 16derivative of the melting curves. Each temperature ramp
was repeated three times and the mean and SD of the
replicates is reported.
Array probing with RNA
Samples for screening and electrophoretic analysis were
obtained with the Dy547 label (Fluorescence properties
similar to Cy3) at the 50-end. Deprotected RNA precipi-
tates were re-dissolved in PBS to a concentration of 5mM.
The resulting solution was heated brieﬂy to 958C, then
allowed to cool slowly to room temperature. The cooled
solution (80ml) was applied to an array and covered with a
glass coverslip. After 1h, the array was washed four times
brieﬂy with PBS followed by a brief wash in deionized
water and centrifugal drying. The array was scanned on
a GenePix 4100A scanner (Axon Instruments) with laser
excitation at 532nm and a 550–600nm emission ﬁlter
(Cy3 emission maximum at 570nm). Results were ana-
lyzed with GenePix Pro software. Each RNA sample
was applied to three replicate arrays. To be considered
positive, an array feature (spot) was required to have ﬂu-
orescence signal above background in each replicate trea-
ted with RNA I, and features with a high ﬂuorescence
prior to application of RNA were disregarded. Features
with ﬂuorescence signal above background in any one of
three replicates with control RNA II were disregarded.
The two positive hit compounds and a negative control
compound were identiﬁed by MS/MS analysis (ABI 4700
proteomics analyzer) of the stock solutions of the library
members spotted to the positive features.
Fluorescence binding assay
RNA samples with 2-aminopurine (2-ap) substituted for
adenine were deprotected according to vendor protocol,
precipitated with ethanol and sodium acetate, and dis-
solved in PBS to a concentration of 5mM. The resulting
solution was heated brieﬂy to 958C, then allowed to cool
slowly to 258C. The RNA was diluted to 1mM with the
assay buﬀer: PBS, 10mM KCl, 50mM Tris, pH 8.5, 1mM
MgCl2 (same as in-line cleavage conditions) or 10mM
potassium phosphate, pH 7.2, 140mM potassium acetate
and 2mM MgCl2. Ligand solutions were prepared as
serial dilutions in assay buﬀer, and equal volumes of
ligand and RNA were mixed prior to delivery to wells of
a standard black 96-well plate. The ﬁnal RNA concentra-
tion in each well was 0.5mM. Background ﬂuorescence
from the ligand was assessed in wells containing ligand
at each ﬁnal concentration in the absence of RNA.
Fluorescence was measured on a SpectraMax M5 plate
reader (Molecular Devices), with excitation at 320nm,
emission measured at 390nm and a 325nm cut-oﬀ ﬁlter.
Equilibrium was conﬁrmed by comparison of data sets
separated by 30min. The dissociation constant was deter-
mined by ﬁtting a sigmoidal dose–response curve to
the mean ﬂuorescence of triplicate measurements after
subtraction of background ﬂuorescence due to ligand.
The error bars on graphs represent 1 SD from the mean,
in many cases smaller than the data marker. Three inde-
pendent determinations of each dissociation constant were
made, and the mean and standard deviation are reported.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) measurements were
made at 258C with a MicroCal VP-ITC (MicroCal, Inc.).
A 1mM solution of compound 2 in PBS was injected in
8ml aliquots into the sample cell containing 1.4ml of
70mM RNA solutions in PBS or buﬀer alone. Injection
was over 16s, with 240s between injections. The area
under the curve of microcalories per second versus sec-
onds was integrated for each injection (using Origin ver-
sion 7.0 software, MicroCal, Inc.) to derive the heat
associated with each injection. The heat associated with
ligand solvation, measured by injection of ligand into
buﬀer alone, was subtracted from the corresponding
heat from injection of the ligand into the RNA solution
to determine the heat due to association of the ligand with
the RNA. A single-site binding model was used to ﬁt the
binding curves from which thermodynamic parameters
were obtained.
Analysis of Mg
2+-induced RNA cleavage
The precipitate of deprotected RNA (50-labeled with
Dy547) was dissolved in 0.1X PBS to a ﬁnal concentration
of 15mM, then heated brieﬂy to 958C and allowed to cool
slowly (over  2h) to room temperature. The resulting
RNA was incubated, at a ﬁnal concentration of 3mM, in
10mM KCl, 50mM Tris, pH 8.5. MgCl2 and peptoid were
added to speciﬁed concentrations as stock solutions. Each
reaction was done in triplicate. Reaction mixtures were
incubated at room temperature in darkness for 10 days,
then precipitated with ethanol, sodium acetate and 5mgo f
yeast phenylalanine tRNA. Alkaline hydrolysis was car-
ried out in 10mM NaHCO3, pH 9.0, at 958C for 4min.
Ribonuclease T1 digestion was carried out with 0.007U of
ribonuclease T1 (Ambion) in 20mM Tris, pH 7.15, 50mM
NaCl, 0.1mM MgCl2, at room temperature for 20min.
The reaction was stopped by addition of 0.2 volumes of
5mM ethylenediaminetetraacetic acid (EDTA) and pre-
cipitation with ethanol, sodium acetate and 5mg of yeast
phenylalanine tRNA. The precipitates were heated brieﬂy
at 958C in formamide prior to analysis by electrophoresis
on a polyacrylamide gel (20%, 19:1 crosslinking, 8M
urea). The gel was visualized by ﬂuorescence (532nm exci-
tation) with a Typhoon 9200 scanner (Amersham
Biosciences) and analyzed with ImageQuant software.
Fraction cleavage at speciﬁc positions was calculated
from the background-corrected ﬂuorescence in the band
associated with that position divided by the background-
corrected total ﬂuorescence in the gel lane. Triplicate mea-
surements were averaged and the dissociation constant
calculated by ﬁtting a sigmoidal dose–response curve
to the data using GraphPad Prism.
RESULTS
Microarray synthesis and screening
Microarrays were created from a combinatorial library of
peptoids (Figure 1A). The library was constructed from
a chemically diverse set of 21 monomers (Figure 1B). An
arginine was present at the C-terminal side of each peptoid
Nucleic Acids Research, 2009,Vol.37, No. 16 5489trimer in the library. Arginine binds with low aﬃnity
(Kd>2mM) to many RNA molecules, including HIV
TAR RNA (40) and group I introns (41), and was
included to provide a ‘toe-hold’ for additional speciﬁc
binding interactions. A linker comprising two glycines
and ending in a cysteine enabled covalent attachment of
the library elements to maleimide-derivatized glass slides
(35,42). The library was robotically spotted onto micro-
arrays, each with a total of 8736 spots.
The arrays were screened to identify ligands speciﬁc for
an RNA hairpin corresponding to the primary transcript
of miR-21 (Figure 2A, RNA I). MiR-21hp with a ﬂuores-
cent label at its 50-end was applied to a peptoid array, and
after washing, spots to which it bound were identiﬁed.
Features with a ratio of signal to local background
(SNR)  1.2, the threshold for visibly discernable ﬂuores-
cence on the scanned image, were considered to have signal
above background. To be considered positive, an array
feature was required to have ﬂuorescence signal above
background in each of three replicate arrays treated with
labeled RNA I. The requirement for reproducibility on
three arrays was imposed to minimize false positives due
to washing artifacts (e.g. water spots) or other irregularities
on the array (e.g. scratches). None of the control features
(arginine and linker only) or features with a single
peptoid residue had signal above background. 891 of the
library features (12%) were ﬂuorescent above background.
The SNR of these features ranged from 1.2 to 468, with a
mean SNR of 7.9 and a median value of 2.2.
A dye-labeled control hairpin (Figure 2A, RNA II) was
tested to eliminate from consideration peptoids with a
high nonspeciﬁc aﬃnity for RNA hairpins or for the dye
molecule and to narrow the search for peptoids that rec-
ognize distinctive features of the miR-21 precursor hair-
pin. This control hairpin was similar to the target hairpin,
but diﬀered from it in several respects to allow for the
possibility of recognizing various features of the target.
The most distinctive features of the target RNA’s pre-
dicted structure were judged to be the adjacent G U
base pairs, the bulged U, and the loop sequence.
Therefore, in the control hairpin, the G U pairs were
changed to G C pairs, the bulged U was omitted and
the loop sequence was scrambled, maintaining the base
composition but changing the sequence order.
Most of the 891 features that were ﬂuorescent above
background after treatment with hairpin I were also ﬂuo-
rescent on one or more of three replicate arrays treated
with RNA II. Examples of such features can be seen
in Figure 2B–E, identiﬁable as ﬂuorescent features not
indicated with an arrow. These features were considered
to be nonspeciﬁc in their aﬃnity for the labeled RNA,
though some might have speciﬁcity for the target that
was not distinguished at the level of stringency of the bind-
ing and washing conditions used. Sequencing some of
+
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Figure 1. Composition of peptoid microarrays. (A) Spots included a combinatorial library of peptoids with three variable peptoid monomers
followed by an arginine and a linker. Control spots included linker only and linker with one peptoid monomer. Each spot contained one compound.
(B) Amines used in library synthesis, shown with the substituents as they are after deprotection to illustrate the composition of the ﬁnal library. The
amine groups shown in blue are incorporated into the amide backbone during peptoid synthesis.
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revealed them to be rich in monomers h and i (Figure 1B).
Two spots were identiﬁed that reproducibly had speciﬁc
aﬃnity for miR-21hp (Figure 2). The SNR of the feature
indicated by the arrow in Figure 2B and C was 1.6, 1.7 and
1.3 in three replicate experiments with RNA I (2B);
whereas it was 1.1, 0.83 and 1.0 in replicate experiments
with RNA II (2C). The SNR of the feature indicated by
the arrow in Figure 2D and E was 8.3, 3.7 and 14 in three
replicate experiments with RNA I (2D); whereas it was
0.9, 0.9 and 1.0 in replicate experiments with RNA II
(2E). These features were revealed by mass spectral ana-
lysis to be compounds 1 and 2 (Figure 3). Compound 3,
identiﬁed from a spot to which neither RNA bound, was
made and tested in solution binding assays for compari-
son. Binding of ligands to the RNA hairpins in solution
was assessed using the base analogue 2-ap as a ﬂuorescent
probe (43,44). The ﬂuorescent base was substituted for the
adenine indicated in Figure 2, and the peptoid-dependent
change in ﬂuorescence was used to determine the
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Figure 2. Screening peptoid microarrays with labeled RNA. (A) RNAs used to probe the arrays. A ﬂuorescent dye moiety, Dy547, was appended to
the 50-end of each RNA for microarray screening. The adenosines in large blue type were replaced with 2-ap in subsequent experiments to determine
dissociation constants by ﬂuorescence. RNA I (miR-21hp) corresponds to the hairpin from the primary transcript of miR-21. RNA II (control) was
used as a control for speciﬁcity. The secondary structures shown for RNAs I and II are predicted by the mfold program (54), and the melting
temperatures (Tm) shown are invariant between 1 and 10mM, conﬁrming unimolecular structures. (B–E) Fluorescence scans of microarray regions
containing lead compounds. A grid of circles is overlayed on the scan to indicate the pattern of spotting. The grid was aligned with ﬂuorescent spots
created by printing a ﬂuorescein-labeled peptoid at known positions. Each circle corresponds to an area with diameter of 270mm. (B) and (C) Region
of peptoid microarray containing the feature (indicated by the arrow) corresponding to 1 after treatment with (B) labeled RNA I or (C) labeled RNA
II. (D) and (E) Region of the peptoid microarray containing the feature (indicated by the arrow) corresponding to compound 2 after treatment with
(D) labeled RNA I or (E) labeled RNA II.
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Figure 3. Compounds identiﬁed in microarray screen. Compound 1 corresponds to the indicated array feature in Figure 2B. Compound 2 corre-
sponds to the indicated array feature in Figure 2D. Compound 3 was identiﬁed from an array feature to which neither RNA bound. Solution-phase
dissociation constants (mM) measured by monitoring 2-ap ﬂuorescence are shown for RNAs I and II. Reported dissociation constants are the
mean SD for three independent determinations.
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with the RNA typically results in a 20–30% decrease in
2-ap ﬂuorescence. In one case, the complex of miR-21hp
(RNA I) with compound 2, binding of the peptoid results
in an increase in ﬂuorescence by 30% (Figure 4B). No
change in ﬂuorescence is observed with peptoid concentra-
tions up to 1mM when 2-ap is substituted for A7 (data
not shown). Dissociation constants determined by this
method are shown in Figure 3. Binding of compounds 1
and 2 is indeed speciﬁc to RNA I. As anticipated, 3 does
not have speciﬁc aﬃnity for RNA I. It has highest aﬃnity
for RNA II and relatively low aﬃnity for both test RNAs.
The aﬃnities of 1 and 2 for RNA I are similar, but 1 has
higher speciﬁcity for the target RNA.
Fluorescence of 2-ap is commonly used to measure
aﬃnities of ligands for nucleic acids, but this technique
relies on the assumption that the substitution does not
perturb the binding interaction. To test this assumption
for the system of this study, we have compared the
results of this assay with dissociation constants deter-
mined by ITC (see Supplementary Data) and probing
with Mg
2+-induced hydrolytic cleavage (see below and
Supplementary Data). The agreement of these methods
conﬁrms that substitution of 2-ap for adenine does not
perturb the binding interaction.
Effects of compounds 1 and 2 on Mg
2+-induced
cleavage of RNA I
Eﬀects of peptoids 1 and 2 on Mg
2+-induced hydrolytic
cleavage of RNA I were used to characterize their binding
(Figure 5). Hydrolytic cleavage of the RNA backbone
occurs principally through nucleophilic attack of a
20-hydroxyl on the adjacent phosphodiester, displacing
the 50-hydroxyl of the following nucleotide. For this dis-
placement to occur, the attacking 20-hydroxyl must be
in-line with the scissile phosphorus–oxygen bond. Thus,
in-line cleavage is a useful probe of conformational
changes such as those that are frequently induced by
ligand binding (45). The reaction is stimulated by divalent
metal ions such as Mg
2+.
In the absence of peptoid, Mg
2+-induced cleavage
occurs predominantly within the 30-side of the hairpin
loop and, with much lower eﬃciency, after U21
(Figure 5A and B). This pattern is consistent with the
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Figure 5. Analysis of peptoid binding to RNA I by Mg
2+-induced cleavage. (A) Fluorescent scan of polyacrylamide gel for analysis of 50-end labeled
RNA after treatment in the presence (+) or absence ( ) of 1mM MgCl2. Samples were treated with 30, 300 or 3000mM 1 or 2 as indicated. OH and
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1 and 2, respectively.
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Figure 4. Representative binding curves of RNA I with compounds identiﬁed in the microarray screen. Fluorescence of 2-ap, substituted at the
position indicated in bold in Figure 2, was monitored as a function of peptoid concentration. Each point is the mean of three measurements, and
error bars represent the standard deviation in the mean. The data were ﬁt to a logistic dose–response curve from which the dissociation constant was
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5492 Nucleic Acids Research, 2009, Vol. 37,No. 16secondary structure predicted for the hairpin. The pattern
of cleavage changes signiﬁcantly when carried out in
the presence of peptoids 1 and 2. With each, the most
pronounced eﬀect is an increase in cleavage after C19.
Reactivity also increases after G10 and U11 and to a
small extent after U16. There is a discernible decrease in
reactivity after U21. These changes indicate binding of
the peptoids proximal to or within the hairpin loop
with concurrent alteration of the backbone conformation.
The EC50 for enhancement of cleavage at C19 (Figure 5C)
provides apparent dissociation constants for 1 and 2.
Under the conditions of the cleavage assay (1mM
Mg
2+, pH 8.5), these dissociation constants are higher
than measured with 2-ap ﬂuorescence under the screening
conditions. However, dissociation constants measured
by ﬂuorescence and in-line cleavage under equivalent
conditions gave equivalent binding constants (See
Supplementary Data).
RNA determinants of compound 1 affinity
Further characterization was focused on compound 1,
because it has higher speciﬁcity for the target RNA than
2. Dissociation constants of 1 for RNAs III, IV and V
were measured to dissect the contributions of the diﬀer-
ences between RNAs I and II to the diﬀerence in their
aﬃnities (Figure 6). The largest eﬀect on aﬃnity (3- to
4-fold) resulted from scrambling the loop sequence. The
putatively bulged U apparently plays a small but measur-
able role in recognition, its omission increasing the disso-
ciation constant by a factor of  1.5. No apparent eﬀect
on aﬃnity results from changing the G U pairs to G C
pairs. The recognition of both the loop sequence and the
bulge illustrates the rationale for varying several features
of the RNA hairpin in the design of the control hairpin
used for screening.
Contributions of individual monomers to affinity and
specificity of compound 1
To analyze the contributions made by diﬀerent parts
of compound 1 to aﬃnity and speciﬁcity, we measured
aﬃnities of derivatives that were truncated or in which a
side chain was replaced with a methyl group (Figure 7A).
The arg–gly–gly peptide alone has low but measurable
aﬃnity, with some speciﬁcity for the targeted hairpin
(compound 4). As expected, the positively charged side
chain of the arginine is required for binding (compound
7). Unexpectedly, the glycines included as a linker to the
array surface, especially the glycine adjacent to the argi-
nine, contribute to the aﬃnity and speciﬁcity for RNA I
(compounds 5 and 6). Of the variable components of the
library, the amino-terminal residue and its pyridine side
chain are clearly important contributors to aﬃnity and
speciﬁcity (compounds 8 and 9). Replacement of the
hydroxyethyl side chain with a methyl group (compound
10) also signiﬁcantly lowers aﬃnity, indicating its involve-
ment in binding. The furfuryl side chain is of lower signif-
icance for binding, its replacement with a methyl group
(compound 11) having little or no eﬀect on binding.
Improved affinity and specificity by conservative
modification of initial lead compound
A beneﬁt of the peptoid scaﬀold for ligand development is
the ease with which variations can be made toward opti-
mizing lead compounds. Once elements of a lead com-
pound that contribute speciﬁc positive interactions are
identiﬁed, the approach of incrementally varying those
elements to improve the interactions can be applied read-
ily. In a ﬁrst application of this approach to lead com-
pound 1, we focused on the pyridine side chain at the
N-terminus, which appeared to be partly responsible
for speciﬁc aﬃnity. Variants were synthesized in
which the 4-substituted pyridine was replaced by 2- and
3-substituted pyridines (Figure 7, compounds 12 and 13,
respectively). Each of these derivatives had higher aﬃnity
for the target RNA and higher speciﬁcity against binding
to the control hairpin than the parent lead. The best of
these compounds was 13, with a dissociation constant of
1.9mM and an  20-fold discrimination against binding
the control RNA. The aﬃnity of this compound for the
target and control RNAs was also measured in a buﬀer
containing 2mM Mg
2+ (10mM potassium phosphate, pH
7.2, 140mM potassium acetate and 2mM MgCl2),t o
approximate a biological background of divalent cations.
Under these conditions, the Kd increased somewhat, as
expected, to 8.0 2.8mM, but the discrimination against
the control RNA (II) remained at  20-fold, with the Kd
for that RNA being 156 33mM.
DISCUSSION
This work demonstrates the utility of peptoid microarrays
for discovering new ligands for speciﬁc RNAs. Previous
work has employed the microarray format as a quantita-
tive analytical tool to proﬁle the relative aﬃnities and
speciﬁcities of known RNA-binding antibiotics (36–38)
and to ﬁnd improvements to peptide sequences that bind
to an RNA required for packaging HIV (46). Recently,
Labuda and co-workers reported a screen of peptoids in a
microarray format to ﬁnd improved inhibitors of a group
I intron (47). These eﬀorts used libraries of 4–120 diﬀerent
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Nucleic Acids Research, 2009,Vol.37, No. 16 5493RNA-binding compounds. To discover new ligands for a
novel, pre-deﬁned RNA target, we have used the micro-
array platform as a qualitative tool to screen a relatively
large library of 7680 diﬀerent compounds. As a qualitative
screen, it is akin to bead-based library screens, in which a
library of compounds on beads is screened for binding to a
ﬂuorescently labeled biomolecule, and hit compounds are
identiﬁed by visual brightness of individual beads with the
use of a ﬂuorescent microscope (25,48). However, having
the library elements arrayed on a surface allows systematic
consideration of each, which is diﬃcult in the bead-based
format. Also, the ability to perform replicate experiments
allows conﬁrmation of reproducibility and speciﬁcity prior
to hit identiﬁcation and solution-phase testing.
The miR-21 precursor hairpin is a novel target, without
previously known small molecule ligands, and very few
sequence-speciﬁc ligands are known for any RNA hairpin
loop. Thus, we had no a priori expectations for the aﬃ-
nities that library compounds with speciﬁcity for the target
RNA would have. For this initial test of the approach,
our goal was to discover positive and speciﬁc molecular
interactions that can be subsequently utilized toward
making ligands of high aﬃnity and speciﬁcity. We chose
the peptoid scaﬀold for our library, in part, because these
subsequent steps are facilitated by the ease with which
peptoids can be modiﬁed. We attempted to bias our
library toward a baseline aﬃnity of Kd 1–10mM by
including arginine in every library element. The aﬃnity
of the diglycine linker was fortuitous, since we had no
prior expectation that it would contribute to binding.
Together, the arginine and glycine components of the
library contribute 4.9kcal/mol (calculated from the Kd)
to the free energy of association of the library elements
to the target RNA, with a weak speciﬁcity for the target
RNA over the control.
Most of the array features gave no indication of binding
the labeled target RNA, but 12% of them were ﬂuorescent
after its application, some with SNR greater than 100.
Most of these features displayed similar signal to noise
with the control hairpin. The compounds rich in alkyl
amines that were predominant among the peptoids with
high signal to noise are likely to have high aﬃnity for the
RNA because the amines are substantially protonated,
creating an electrostatic attraction for the polyanionic
RNA. While some of these compounds may have speciﬁ-
city for the target RNA that could be revealed by
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as mean SD for three independent measurements. (A) Compounds used to characterize contributions of functional groups of 1 to aﬃnity and
speciﬁcity. (B) Aﬃnities of methyl pyridine positional isomers 12 and 13 for RNAs I and II.
5494 Nucleic Acids Research, 2009, Vol. 37,No. 16screening under more stringent conditions and by rigorous
quantitation of the ﬂuorescent signal, a large nonspeciﬁc
component of binding is likely to interfere with optimiza-
tion of the speciﬁc interactions. Therefore, we focused our
attention on hit compounds that reproducibly showed
no interaction with the control hairpin.
Both of the compounds to which this requirement
narrowed our focus had aﬃnity for the target RNA in
solution 15- to 20-fold higher than the aﬃnity of a com-
pound that did not bind the labeled target on the array
(compound 3). The aﬃnity of compound 3 is comparable
to that of the arginine and linker alone (4). Thus, the array
screen was successful in identifying compounds from the
library that are better ligands than one that shows no
interaction on the array. The variable peptoid components
of the lead compounds identiﬁed contribute  20-fold to
the aﬃnity over the arginine and glycines alone, corre-
sponding to  1.6kcal/mol of additional free energy of
binding. Furthermore, peptoids 1 and 2 share common
features that are not found in other library elements: an
aromatic heterocycle at the N-terminus and an oxygen
three atomic centers from the backbone in the second
position. These similarities suggest involvement of speciﬁc
molecular interactions in the binding of the RNA, sup-
porting the conclusion that the microarray screen success-
fully identiﬁed library elements that form positive, speciﬁc
interactions with the target. Though the signal to noise
ratio of compound 1, near the threshold of being visible,
was signiﬁcantly lower than that of compound 2, the solu-
tion phase aﬃnities of these two compounds for the target
were similar, indicating that ﬂuorescent signal on the array
is inﬂuenced by factors other than solution-phase aﬃnity,
such as linker eﬀects, well known in the interactions of
surface-bound ligands with RNA (36,49).
Though the speciﬁcities of the initial lead compounds
are modest, the 4.7-fold speciﬁcity of 1 is signiﬁcant in
light of the similarity between the target and control hair-
pins and the paucity of ligands reported in the literature
with appreciable sequence speciﬁcity for RNA hairpin
loops. This diﬀerence is all the more signiﬁcant in light
of the fact that it is primarily due to the sequence order
within the ﬁve-nucleotide loop, the loop sequence com-
position being held constant, with little dependence on
other diﬀerences between the target and control hairpins.
Furthermore, much of this speciﬁcity can be attributed to
distinct functional elements of the ligand. The terminal
pyridine and the hydroxyethyl side chain contribute the
majority of the free energy of association that is speciﬁc
to the target RNA.
Although these groups contribute speciﬁc interactions
to the complex, they do not necessarily optimize those
interactions. The potential for enhancing these contacts
suggests an avenue for improvement of the lead com-
pound, by screening a series of derivatives in which a crit-
ical group is incrementally varied. This approach
was immediately productive when applied to the terminal
pyridine of 1. By simply varying the position at which the
pyridine is linked to the backbone, the aﬃnity and speci-
ﬁcity were both increased. The aﬃnities of the resulting
compounds for the target RNA are comparable to the
aﬃnity of DGCR8, the double-stranded RNA-binding
component of the microprocessor complex, for primary
miRNAs (50). This is true for compound 13 in the pres-
ence of physiologically relevant concentrations of mono-
and divalent cations. Development of further optimized
ligands by testing conservative variations of the hydro-
xyethyl side chain is in progress.
The process followed to discover ligand 13 illustrates
a systematic approach to the development of ligands
for speciﬁc, pre-deﬁned RNA molecules. The screen of
a library of potential ligands is the ﬁrst step, aimed at
discovery of speciﬁc interactions. The library is designed
so that its members not only have desirable qualities for
biologically active compounds (cell permeability, limited
size, biological stability), but are also easily modiﬁed in
the subsequent steps, when the structural elements of the
lead compounds that contribute speciﬁc aﬃnity are iden-
tiﬁed and varied to ﬁnd improvements.
Work is underway to test the eﬀects of the ligands found
here on miRNA processing in cell culture and in cell-free
miRNA processing assays and to explore the broader
biological eﬀects of these compounds. Though cleavage
of miRNA precursors by Drosha does not depend on spe-
ciﬁc loop sequences, mutations that stabilize an internal
conformation of the loop diminish or abolish cleavage
(51,52). Thus, a ligand that recognizes, thereby stabilizing,
a hairpin conformation might similarly inhibit processing.
This inhibition could be realized even if the bound con-
formation is diﬀerent from the most stable conformation
in the absence of ligand. The dependence of binding on
loop sequence, the binding-induced change of 2-ap ﬂuo-
rescence when the ﬂuorescent probe is in the hairpin but
not in the stem, and the conformational changes within
the loop revealed by Mg
2+-mediated cleavage indicate
that the binding site for the compounds identiﬁed in this
study includes the loop. A small molecule that binds to a
miRNA precursor might also interfere with endogenous
factors that interact with the hairpin loop to stimulate
cleavage by Drosha (13) or with processing steps that
follow Drosha cleavage, including removal of the loop
or intracellular localization (53). In any of these cases, a
compound that speciﬁcally interferes with maturation of
miR-21 will be a useful tool for understanding miRNA
regulation and could be of therapeutic value.
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